LPL Financial »

Unicycive Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $190k 466k 0.41
2024-06-30 $43k 85k 0.50

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)

View all positions for LPL Financial

Top funds holding Unicycive Therapeutics

Octagon Capital Advisors
Dr. Jeffrey R. Jay, M.D.
Logos Global Management
Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
LPL Financial
Geode Capital Management
Goldman Sachs Group
Bleakley Financial Group
BlackRock
BlackRock
State Street Corporation
Jane Street
Northern Trust

View all funds holding Unicycive Therapeutics